UNSPSC 51282405: Carindacillin

This classification denotes an anti-bacterial agent with the molecular formula C26H26N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V278481KE, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1h-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as carindacillin, which bears US NIH Compound Identifier 93184. carindacillin most often comes in base and sodium forms.

UNSPSC 51282405 Carindacillin is a Commodity code. Recent state and local opportunities posted under this code show a significant mismatch with the pharmaceutical ingredient carindacillin itself; instead, the actual procurements being tagged to this code span emergency response pharmaceuticals, pharmacy benefit administration, medical and first aid supplies, and generic multi-source pharmaceutical distribution. Issuing bodies include county health departments, state HHS commissions, municipal fire departments, and multistate cooperative purchasing alliances. The scope of work centers on the acquisition, distribution, and administrative management of pharmaceutical products—from opioid-reversal agents like naloxone purchased by Seminole County, Florida for community health initiatives, to generic pharmaceuticals and OTC products distributed through authorized wholesalers under cooperative purchasing agreements, to emergency medical supplies procured by city fire departments for rescue operations. This reflects state and local government's use of pharmaceutical procurement codes to encompass not only raw active pharmaceutical ingredients but also finished pharmaceutical products, medical consumables, and the vendor relationships required to distribute them.

Opportunities span Florida, Texas, Minnesota, and Oregon. Recent representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a due date of July 26, 2026; the Texas Health and Human Services Commission's RFI (HHS0017013) to explore direct-to-manufacturer prescription programs with a response deadline of April 3, 2026; the City of Tampa's IFB for 169 line items of emergency medical supplies for its Fire Department Rescue Division with a due date of March 13, 2026 and an estimated contract value of $700,000.00 designated as a sheltered market opportunity for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802) to establish multiple contracts for generic pharmaceuticals and OTC products with a due date of March 26, 2026, requiring vendors to supply through three authorized wholesalers and comply with cGMP and DSCSA requirements. The Tampa procurement includes a 5% SLBE bid discount, while MMCAP imposes a 3% administrative fee on all contract purchases and performance penalties for late reporting or missed onboarding timelines.